Financial results for the period ended September 30, 2026
As filed · Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
What happened
FactFinancial results for the period ended September 30, 2026. alia, have taken on record the Unaudited Financial Results for the quarter ended on 30™ September, 2026. 2026 — Integrated Filing (Financial) along with Auditors’ Limited Review Report thercon as Annexure.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
RevisedSo, there we can look around doubling the sale year over year so that what we are trying to do this year as well as planning for the next year also which I have already told around 3x of the previous year figure what we achieved.
Roughly it was INR35 crores last year domestic CMO and this year we are going to double that number.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- in the next year we are trying to reach total number of 100 plus dossier approvals or registrations which will (management committed by FY28)
- we are looking to double that number. (management committed by FY27)
Evidence
- Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%